Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Self-Adjuvanted Nanoparticles as an HIV Vaccine Platform
FY 2017-18
Summary
Over the past 25 years, efforts have failed to develop a vaccine capable of broadly protecting against HIV. In response to HIV, the human immune system seems generally unable to respond effectively, providing limited protection to the infected individual. Past HIV vaccine candidates have been met with similar challenges, where they are unable to elicit a broadly protective response. Thus, improvements must be made to increase specificity and breadth of the immune response to an HIV vaccine. Towards this goal, subunit HIV components (antigens) displayed in high-density have been demonstrated to be more effective in activating the immune system in comparison to monomeric antigens, due to their ability to activate several receptors on immune cells (B cells) simultaneously. In order to improve current HIV antigens and create an improved immune response, I propose to design a novel platform based on self-assembling protein-based nanoparticles to co-deliver multimers of HIV antigens and immunomodulatory proteins to the immune system. I will then test these nanoparticles in vitro in B cells and in immunization trials with animal models to determine their potential for immune activation and antibody production. It is predicted that the development of protein nanoparticles as an immunomodulatory platform for HIV antigens will enable broader reactivity and enhanced immunity to vastly improve the efficiency of current HIV vaccination strategies.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
376546
Name
Sicard Taylor
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Self-Adjuvanted Nanoparticles as an HIV Vaccine Platform
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
B Cells; Hiv; Protein Engineering; Self-Assembling Nanoparticles; Vaccines
Abstract
Over the past 25 years, efforts have failed to develop a vaccine capable of broadly protecting against HIV. In response to HIV, the human immune system seems generally unable to respond effectively, providing limited protection to the infected individual. Past HIV vaccine candidates have been met with similar challenges, where they are unable to elicit a broadly protective response. Thus, improvements must be made to increase specificity and breadth of the immune response to an HIV vaccine. Towards this goal, subunit HIV components (antigens) displayed in high-density have been demonstrated to be more effective in activating the immune system in comparison to monomeric antigens, due to their ability to activate several receptors on immune cells (B cells) simultaneously. In order to improve current HIV antigens and create an improved immune response, I propose to design a novel platform based on self-assembling protein-based nanoparticles to co-deliver multimers of HIV antigens and immunomodulatory proteins to the immune system. I will then test these nanoparticles in vitro in B cells and in immunization trials with animal models to determine their potential for immune activation and antibody production. It is predicted that the development of protein nanoparticles as an immunomodulatory platform for HIV antigens will enable broader reactivity and enhanced immunity to vastly improve the efficiency of current HIV vaccination strategies.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Sicard, Taylor
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~